-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2019-07-15
Values as of: 2019-07-15
The investment seeks to track the performance of the MSCI USA Factor Mix A-Series Capped Index. The fund invests at least 80%, of its total assets in the securities comprising the index. The index is designed to measure the equity market performance of large-and mid-cap companies across the U.S. equity market. It aims to represent the performance of a combination of three factors: value, quality, and low volatility. It is an equal weighted combination of the following three MSCI Factor Indices in a single composite index: the MSCI USA Value Weighted Index, the MSCI USA Quality Index, and the MSCI USA Minimum Volatility Index. The fund is non-diversified.
Company Website : www.spdrs.com
Currency: USD
Country : USA
Inception Date: 15/04/2015
Primary Benchmark: MSCI USA Factor Mix A-SersCap(USD)NR USD
Primary Index: S&P 500 TR USD
Gross Expense Ratio: 0.15%
Management Expense Ratio: 0.15 %
N/A
N/A
Symbol | Company Name | Allocation |
---|---|---|
CVE | Cenovus Energy Inc | 1.74 % |
EMMA | Emmaus Life Sciences Inc | 1.50 % |
N/A
N/A
Symbol | Name | Mer | Price(Change) | Market Cap |
---|---|---|---|---|
SOJE | SOJE | 0.00 % |
+0.07 (+0.37%) |
USD 65.72B |
JEPI | JPMorgan Equity Premium Income.. | 0.00 % |
-0.12 (-0.22%) |
USD 32.78B |
LCR | Leuthold Core ETF | 0.00 % |
-0.09 (-0.28%) |
USD 32.52B |
DTB | DTB | 0.00 % |
+0.21 (+1.12%) |
USD 26.58B |
DFAC | Dimensional U.S. Core Equity 2.. | 0.00 % |
-0.17 (-0.56%) |
USD 26.11B |
JPST | JPMorgan Ultra-Short Income ET.. | 0.00 % |
+0.02 (+0.04%) |
USD 22.47B |
SGOV | iShares® 0-3 Month Treasury B.. | 0.00 % |
+0.03 (+0.03%) |
USD 18.58B |
TSPA | T. Rowe Price US Equity Resear.. | 0.00 % |
-0.20 (-0.64%) |
USD 16.23B |
DFUV | Dimensional US Marketwide Valu.. | 0.00 % |
-0.13 (-0.34%) |
USD 10.15B |
AVUV | Avantis® U.S. Small Cap Value.. | 0.00 % |
-0.83 (-0.95%) |
USD 10.05B |
Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange (NYSE Arca) | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 21.55% | 84% | B | 74% | C | ||
Dividend Return | N/A | N/A | N/A | N/A | F | ||
Total Return | 21.55% | 81% | B- | 70% | C- | ||
Trailing 12 Months | |||||||
Capital Gain | 10.45% | 89% | A- | 80% | B- | ||
Dividend Return | N/A | N/A | N/A | N/A | F | ||
Total Return | 10.45% | 86% | B+ | 74% | C | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | F | ||
Dividend Return | N/A | N/A | N/A | N/A | F | ||
Total Return | N/A | N/A | N/A | N/A | F | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 8.53% | 84% | B | 63% | D | ||
Dividend Return | 9.85% | 64% | D | 62% | D | ||
Total Return | 1.32% | 45% | F | 35% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 7.85% | 62% | D | 91% | A- | ||
Risk Adjusted Return | 125.44% | 88% | B+ | 97% | N/A | ||
Market Capitalization | 0.01B | 66% | D+ | 38% | F |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The company had positive total cash flow in the most recent four quarters.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.